Loading...
Innovative MedTech Inc.
IMTH•PNK
Healthcare
Medical - Instruments & Supplies
$0.10
$-0.04(-28.32%)
Innovative MedTech Inc. (IMTH) Financial Performance & Income Statement Overview
Review Innovative MedTech Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
5.80%
↑ 5.80%
Operating Income Growth
-17.93%
↓ 17.93%
Net Income Growth
-117.63%
↓ 117.63%
Operating Cash Flow Growth
-8.38%
↓ 8.38%
Operating Margin
-438.20%
↓ 438.20%
Gross Margin
79.93%
↑ 79.93%
Net Profit Margin
-715.99%
↓ 715.99%
ROE
229.38%
↑ 229.38%
ROIC
205.35%
↑ 205.35%
Innovative MedTech Inc. (IMTH) Income Statement & Financial Overview
Review Innovative MedTech Inc.'s (IMTH) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $428384.00 | $456361.00 | $455164.00 |
| Cost of Revenue | $0.00 | $239260.00 | $14460.00 | $15197.00 |
| Gross Profit | $0.00 | $189124.00 | $441901.00 | $439967.00 |
| Gross Profit Ratio | $0.00 | $0.44 | $0.97 | $0.97 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $61109.00 | $1.24M | $3.52M | $1.34M |
| Operating Expenses | $1.07M | $1.26M | $3.51M | $1.34M |
| Total Costs & Expenses | $1.07M | $1.26M | $3.52M | $1.36M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $33572.00 | $50673.00 | $59665.00 | $38644.00 |
| Depreciation & Amortization | -$1292.00 | $13369.00 | $4576.00 | $15197.00 |
| EBITDA | -$1.08M | -$819488.00 | -$6.60M | -$856030.00 |
| EBITDA Ratio | $0.00 | -$1.91 | -$14.47 | -$1.95 |
| Operating Income | -$1.07M | -$826744.00 | -$3.07M | -$902010.00 |
| Operating Income Ratio | $0.00 | -$1.93 | -$6.72 | -$1.98 |
| Other Income/Expenses (Net) | -$34864.00 | -$56787.00 | -$3.61M | -$7865.00 |
| Income Before Tax | -$1.11M | -$883531.00 | -$6.68M | -$909871.00 |
| Income Before Tax Ratio | $0.00 | -$2.06 | -$14.63 | -$2.00 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $3.00 |
| Net Income | -$1.12M | -$883531.00 | -$6.68M | -$909871.00 |
| Net Income Ratio | $0.00 | -$2.06 | -$14.63 | -$2.00 |
| EPS | -$0.04 | -$0.03 | -$0.28 | -$0.04 |
| Diluted EPS | -$0.04 | -$0.03 | -$0.28 | -$0.04 |
| Weighted Avg Shares Outstanding | $30.89M | $27.72M | $23.88M | $21.16M |
| Weighted Avg Shares Outstanding (Diluted) | $30.89M | $27.72M | $23.88M | $21.16M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan